FDA Inspection 1309962 — ARS Pharmaceuticals Operations
The FDA completed an inspection of ARS Pharmaceuticals Operations on March 13, 2026 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Diego, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)